New neuroimaging marker may identify persons at risk of dementia in future clinical trials

A new neuroimaging marker of cerebral small vessel disease is related to general cognition and may serve to identify persons at risk of dementia in future clinical trials, a landmark study has found.

Bicycle Therapeutics Plc Patent: High Affinity Nectin-4 Binders for Disease Treatment

Share this article According to GlobalData’s company profile on Bicycle Therapeutics, Nanoparticle drug conjugates was a key innovation area identified from patents. Bicycle Therapeutics‘s grant

April 24, 2024

Digital dilemma in UK’s life sciences job market – Pharmaceutical Technology

Manasi Vaidya @manasivaidya22 A recent report commissioned by the Association of British Pharmaceutical Industry has indicated that UK pharma companies are prioritising filling the data

September 8, 2023

Improving access to transgender-friendly health care can help decrease the burden on ERs

Transgender people who come to the emergency room for care tend to be sicker than cisgender people who are otherwise similar to them and are

June 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.